176 related articles for article (PubMed ID: 23824644)
21. European Research on Electrochemotherapy in Head and Neck Cancer (EURECA) project: Results from the treatment of mucosal cancers.
Plaschke CC; Bertino G; McCaul JA; Grau JJ; de Bree R; Sersa G; Occhini A; Groselj A; Langdon C; Heuveling DA; Cemazar M; Strojan P; Leemans CR; Benazzo M; De Terlizzi F; Wessel I; Gehl J
Eur J Cancer; 2017 Dec; 87():172-181. PubMed ID: 29156298
[TBL] [Abstract][Full Text] [Related]
22. Involvement of c-Fos in the Promotion of Cancer Stem-like Cell Properties in Head and Neck Squamous Cell Carcinoma.
Muhammad N; Bhattacharya S; Steele R; Phillips N; Ray RB
Clin Cancer Res; 2017 Jun; 23(12):3120-3128. PubMed ID: 27965308
[No Abstract] [Full Text] [Related]
23. The Association and Clinical Significance of CDKN2A Promoter Methylation in Head and Neck Squamous Cell Carcinoma: a Meta-Analysis.
Zhou C; Shen Z; Ye D; Li Q; Deng H; Liu H; Li J
Cell Physiol Biochem; 2018; 50(3):868-882. PubMed ID: 30355925
[TBL] [Abstract][Full Text] [Related]
24. Frequent 3p allele loss and epigenetic inactivation of the RASSF1A tumour suppressor gene from region 3p21.3 in head and neck squamous cell carcinoma.
Hogg RP; Honorio S; Martinez A; Agathanggelou A; Dallol A; Fullwood P; Weichselbaum R; Kuo MJ; Maher ER; Latif F
Eur J Cancer; 2002 Aug; 38(12):1585-92. PubMed ID: 12142046
[TBL] [Abstract][Full Text] [Related]
25. Epigenetic inactivation of galanin and GALR1/2 is associated with early recurrence in head and neck cancer.
Misawa K; Misawa Y; Kanazawa T; Mochizuki D; Imai A; Endo S; Carey TE; Mineta H
Clin Exp Metastasis; 2016 Feb; 33(2):187-95. PubMed ID: 26572146
[TBL] [Abstract][Full Text] [Related]
26. Assessment of p53 functional activity in tumor cells and histologically normal mucosa from patients with head and neck squamous cell carcinoma.
Van der Vorst S; Dekairelle AF; Weynand B; Hamoir M; Gala JL
Head Neck; 2012 Nov; 34(11):1542-50. PubMed ID: 22109999
[TBL] [Abstract][Full Text] [Related]
27. The prognostic value of glycerol-3-phosphate dehydrogenase 1-like expression in head and neck squamous cell carcinoma.
Feng Z; Li JN; Wang L; Pu YF; Wang Y; Guo CB
Histopathology; 2014 Feb; 64(3):348-55. PubMed ID: 24274692
[TBL] [Abstract][Full Text] [Related]
28. Characterization of gene methylation in human papillomavirus associated-head and neck squamous cell carcinoma.
Zhang HZ; Shan CG; Huang AP; Wang JM
Genet Mol Res; 2016 Aug; 15(3):. PubMed ID: 27706614
[TBL] [Abstract][Full Text] [Related]
29. Over-expression of BAG-1 in head and neck squamous cell carcinomas (HNSCC) is associated with cisplatin-resistance.
Liu S; Ren B; Gao H; Liao S; Zhai YX; Li S; Su XJ; Jin P; Stroncek D; Xu Z; Zeng Q; Li Y
J Transl Med; 2017 Sep; 15(1):189. PubMed ID: 28877725
[TBL] [Abstract][Full Text] [Related]
30. Persistence of genetically altered fields in head and neck cancer patients: biological and clinical implications.
Tabor MP; Brakenhoff RH; van Houten VM; Kummer JA; Snel MH; Snijders PJ; Snow GB; Leemans CR; Braakhuis BJ
Clin Cancer Res; 2001 Jun; 7(6):1523-32. PubMed ID: 11410486
[TBL] [Abstract][Full Text] [Related]
31. Unknown primary head and neck squamous cell carcinoma: molecular identification of the site of origin.
Califano J; Westra WH; Koch W; Meininger G; Reed A; Yip L; Boyle JO; Lonardo F; Sidransky D
J Natl Cancer Inst; 1999 Apr; 91(7):599-604. PubMed ID: 10203278
[TBL] [Abstract][Full Text] [Related]
32. DNA Methylation as a Diagnostic, Prognostic, and Predictive Biomarker in Head and Neck Cancer.
Liouta G; Adamaki M; Tsintarakis A; Zoumpourlis P; Liouta A; Agelaki S; Zoumpourlis V
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769317
[TBL] [Abstract][Full Text] [Related]
33. Head and neck squamous cell carcinoma: mismatch repair immunohistochemistry and promoter hypermethylation of hMLH1 gene.
Tawfik HM; El-Maqsoud NM; Hak BH; El-Sherbiny YM
Am J Otolaryngol; 2011; 32(6):528-36. PubMed ID: 21353335
[TBL] [Abstract][Full Text] [Related]
34. DNA global hypomethylation in squamous cell head and neck cancer associated with smoking, alcohol consumption and stage.
Smith IM; Mydlarz WK; Mithani SK; Califano JA
Int J Cancer; 2007 Oct; 121(8):1724-8. PubMed ID: 17582607
[TBL] [Abstract][Full Text] [Related]
35. Clinical benefit of nanoparticle albumin-bound-paclitaxel in recurrent/metastatic head and neck squamous cell carcinoma resistant to cremophor-based paclitaxel or docetaxel.
Ley J; Wildes TM; Daly K; Oppelt P; Adkins D
Med Oncol; 2017 Feb; 34(2):28. PubMed ID: 28078561
[TBL] [Abstract][Full Text] [Related]
36. Clinical significance of molecular alterations in histologically negative surgical margins of head and neck cancer patients.
de Carvalho AC; Kowalski LP; Campos AH; Soares FA; Carvalho AL; Vettore AL
Oral Oncol; 2012 Mar; 48(3):240-8. PubMed ID: 22104250
[TBL] [Abstract][Full Text] [Related]
37. Short-term culture of tumour slices reveals the heterogeneous sensitivity of human head and neck squamous cell carcinoma to targeted therapies.
Donnadieu J; Lachaier E; Peria M; Saidak Z; Dakpe S; Ikoli JF; Chauffert B; Page C; Galmiche A
BMC Cancer; 2016 Apr; 16():273. PubMed ID: 27085492
[TBL] [Abstract][Full Text] [Related]
38. Independent evaluation of a FOXM1-based quantitative malignancy diagnostic system (qMIDS) on head and neck squamous cell carcinomas.
Ma H; Dai H; Duan X; Tang Z; Liu R; Sun K; Zhou K; Chen H; Xiang H; Wang J; Gao Q; Zou Y; Wan H; Teh MT
Oncotarget; 2016 Aug; 7(34):54555-54563. PubMed ID: 27409343
[TBL] [Abstract][Full Text] [Related]
39. FDG-PET/contrast-enhanced CT as a post-treatment tool in head and neck squamous cell carcinoma: comparison with FDG-PET/non-contrast-enhanced CT and contrast-enhanced CT.
Suenaga Y; Kitajima K; Ishihara T; Sasaki R; Otsuki N; Nibu K; Minamikawa T; Kiyota N; Sugimura K
Eur Radiol; 2016 Apr; 26(4):1018-30. PubMed ID: 26188656
[TBL] [Abstract][Full Text] [Related]
40. A phase II study of temsirolimus added to low-dose weekly carboplatin and paclitaxel for patients with recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC).
Dunn LA; Fury MG; Xiao H; Baxi SS; Sherman EJ; Korte S; Pfister C; Haque S; Katabi N; Ho AL; Pfister DG
Ann Oncol; 2017 Oct; 28(10):2533-2538. PubMed ID: 28961834
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]